Brian Jeansonne on living beyond his ALS prognosis
Oct 5, 2026, 2:34 PM CDT
Author Brian Jeansonne was given five years to live when doctors diagnosed him with ALS. Six and a half years later, Jeansonne is continuing his battle. Jeansonne and his son and caregiver, Nate, join CBS News to discuss how they've approached life since that diagnosis.
Excerpt shown under fair-use limits. Full text remains with the original publisher.
People in this coverage
Explore their history and attributable record. Being mentioned does not imply endorsement.
Layer 1 · Claims & fact checks
AI analysisLayer 3 · Reporting analysis
AI analysisEmotional appealThe language emphasizes perseverance and hope, aiming to evoke empathy and inspiration.
Personal narrativeThe focus on the individual's story frames the piece as a human‑interest feature rather than a factual report.
Context
AI analysisMissing context
The piece does not provide medical context about ALS prognosis statistics, treatment options, or how typical survival times compare to the five‑year estimate given to Jeansonne.
Important context
ALS (amyotrophic lateral sclerosis) is a progressive neurodegenerative disease with a median survival of 2‑5 years after diagnosis, though individual outcomes vary widely.
Opinion vs. reporting
AI analysisThe article is primarily a personal narrative/feature interview rather than investigative reporting; it presents the subject’s perspective without independent verification.